Skip to content

Feargal Sharkey acknowledges his prostate cancer diagnosis publicly.

Diagnosed with cancer after a sore throat: Singer-turned-ecological-advocate Feargal Sharkey shares his health battle

Diagnosed with cancer in 2020, musician and eco-activist Feargal Sharkey initially sought medical...
Diagnosed with cancer in 2020, musician and eco-activist Feargal Sharkey initially sought medical help for a persistent sore throat, as stated by him.

Feargal Sharkey acknowledges his prostate cancer diagnosis publicly.

British singer and environmentalist Feargal Sharkey has disclosed that he was diagnosed with prostate cancer last year following a routine check-up for a persistent sore throat.

In an interview with the Daily Express, the Water Campbell and former frontman of Derry band The Undertones shared his experiences and urged men to prioritize their health. Sharkey mentioned that his doctor, a "charming, grumpy, and candid" elderly practitioner, ran a battery of tests for his 65th birthday.

Two days later, Sharkey discovered he was on a journey towards a prostate cancer diagnosis. He emphasized the importance of staying informed and proactive about one's health options, as one in eight men in the UK may be affected by this disease.

Doctors can diagnose prostate cancer using various methods such as digital rectal examinations (DRE), blood tests, biopsies, and magnetic resonance imaging (MRI) scans. While a prostate-specific antigen (PSA) test is not currently reliable enough for routine NHS screening due to the risk of overdiagnosis and overtreatment, men over 50 can discuss this option with their GP.

Sharkey appealed to men, particularly those over 50, to engage in talks with their healthcare providers about prostate cancer screening. This discussion should take into account the benefits and risks associated with testing and the individual's personal and family health history, age, and life expectancy.

According to guidelines, men who are at average risk for prostate cancer and are aged 50 or older should consider discussing screening options with their healthcare providers, typically involving a PSA blood test and possible DRE. Screening frequency may vary based on initial PSA level and other risk factors.

Men at higher risk, such as African American men or those with a family history of prostate cancer diagnosed before age 65, should initiate these discussions earlier, often starting at age 45 or even 40 for those with multiple affected relatives. The decision to screen should be based on a personalized discussion between patient and clinician about the benefits and risks of testing.

If screening suggests abnormalities, further diagnostic steps, including imaging and a prostate biopsy, might be necessary to confirm cancer presence. Early detection typically leads to more effective treatment options and a better prognosis, although late-stage prostate cancers may not be curable but can be managed to improve quality of life.

In light of Sharkey's experience, men are encouraged to prioritize prostate cancer screening, considering their personal and family health history, age, and life expectancy in their discussions with healthcare providers. This approach aims to detect prostate cancer at a treatable stage while minimizing unnecessary interventions.

Sources: Press Association, National Institute for Health and Care Excellence (NICE), American Cancer Society

  • Feargal Sharkey, the British singer diagnosed with prostate cancer, urges men to prioritize their health, especially regarding medical-conditions like cancer, as part of health-and-wellness and mental-health efforts.
  • Regular check-ups and discussions with healthcare providers, including tests like digital rectal examinations and blood tests, can help detect prostate cancer early and increase the chances of successful treatment and improved mens-health outcomes.
  • Early detection and timely treatment can have a significant impact on the prognosis of prostate cancer, making it crucial for men over 50, or those at higher risk due to family history, to engage in discussions about prostate health and screening options with their healthcare providers.

Read also:

    Latest